CardioLync Unveils Its Diagnostic Interface Portal at the International Conference for Innovations in Cardiovascular Systems Tel Aviv

Atlanta, GA, December 05, 2017 --(PR.com)-- CardioLync unveiled its Diagnostic Interface Portal at the ICI Meeting 2017 – the premier International Conference for Innovations in Cardiovascular Systems (Heart, Brain and Peripheral Vessels) and High-Tech Life Science Industry, will be held in Israel, December 3-5, 2017. Through demonstrating its innovative digital health technology to select leading cardiologists and medical pioneers at this conference, CardioLync has begun introducing clinical practitioners to secure social networking as a tool to improve patient outcomes.

According to Jeremy Kagan, Founder and CEO of CardioLync, "It is no secret that there is a growing shortage of specialist physicians worldwide. Considering that Cardiovascular Disease is the number one cause of death, and 50% of men and 64% of women who die suddenly of heart disease have no previous symptoms, many if not most of these deaths could have been prevented through routine diagnostic tests and follow-up. CardioLync has developed a unique technology that facilitates access to specialist interpreting physicians and engages patients to be more actively involved. The feedback that we are getting from physicians is that CardioLync's technology will help them improve patient outcomes as well as their own bottom lines."

About CardioLync:
CardioLync has developed a Diagnostic Interface Portal that facilitates scheduling, tracking, interpretation and reporting of medical diagnostic studies that include imaging; consolidation of outpatient and monitoring device data; and Doctor-Patient social networking that turns care into a participatory team effort. CardioLync is led by experienced technologists and clinical practitioners looking to solve the needs of ageing populations within the financial constraints of changing medical reimbursement models.